Access 2.8M+ Filings Sign Up Free
CATALYST MEDIA GROUP PLC Logo

CATALYST MEDIA GROUP PLC | CMX - Profile, Filings, Stock Info & Investor Relations Data

CATALYST MEDIA GROUP PLC | CMX
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
United Kingdom
Founded
N/A
CATALYST MEDIA GROUP PLC (CMX)

Company Profile

About CATALYST MEDIA GROUP PLC

Celadon Pharmaceuticals PLC develops and delivers innovative cannabis-based medicines to improve patients' lives, focusing on chronic pain relief.Ê We operate a 100,000 sq ft EU-GMP licensed facility and conduct clinical trials, including an MHRA-approved study.Ê Our R&D efforts generate novel intellectual property. We went public on AIM in 2022.

Headquarters

QUADRANT HOUSE FLOOR 6 4
E1W 1YW, LONDON
United Kingdom

CATALYST MEDIA GROUP PLC (CMX)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Get Notified About CATALYST MEDIA GROUP PLC's New Filings

Receive email alerts when new documents are published.

You can unsubscribe at any time.

CATALYST MEDIA GROUP PLC (CMX)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

CATALYST MEDIA GROUP PLC (CMX)
Stock & Investor Information

ISINs

GB00B282R334
US14887E1082

LEI

213800L5Y3PS1XBYNS14

Stock Exchange Listings

London Stock Exchange

Stock Index Memberships

AIM (LSE)

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals